There is a consensus emerging that surgery is most appropriate for people with severe obesity for whom lifestyle ...

BERLIN, Jan 27 (Reuters) - Roche's experimental obesity drug, which works in a similar way to Eli Lilly's Zepbound, produced ...

The Obesity Association, a division of the American Diabetes Association (ADA), has issued new standards of care on the pharmacologic treatment of obesity and overweight in adults.

A once-weekly injectable GIP/GLP-1 dual agonist conferred up to 22.5% weight loss at 48 weeks for adults with overweight or ...

Swiss pharmaceutical company Roche announced on the 27th (local time) that its obesity treatment pipeline ‘CT-388’ recorded a maximum weight loss effect of 22.5% in Phase 2 clinical trials, as ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

There are a few topics that garner bipartisan support within legislation, and fortunately, obesity is one of them. Recently, weight loss drugs such as Ozempic and Tirzepatide have garnered much ...

Novo Nordisk's FDA-approved Wegovy pill marks a new era in obesity treatment, expanding access to GLP-1 therapy through ...

A new study reveals stopping GLP-1 weight loss drugs leads to rapid weight regain, nearly four times faster than quitting ...

Hardworking Tennesseans like me have tried changes to our diets and exercise to lose weight and maintain healthy lifestyles, but sometimes, those practices are not enough. 2.6 million Tennesseans – ...

Children and adolescents should be proactively evaluated and treated for obesity, according to new guidelines from the American Academy of Pediatrics around childhood obesity. The guidelines note that ...

Lauds the unveiling of a patient empowerment program. MANILA, PHILIPPINES (January 25, 2026) — In a historic partnership ...